Insight into the hepatoprotective, hypolipidemic, and antidiabetic impacts of aliskiren in streptozotocin-induced diabetic liver disease in mice

BACKGROUND: Diabetic hepatopathy is a serious complication of poorly controlled diabetes mellitus. An efficient antidiabetic drug which keeps normal liver tissues is not available. The renin-angiotensin system has been reported to be involved in both diabetic state and liver function. Aliskiren is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahfoz, Amal M., Gawish, Aya Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620647/
https://www.ncbi.nlm.nih.gov/pubmed/36316746
http://dx.doi.org/10.1186/s13098-022-00935-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620647/
https://www.ncbi.nlm.nih.gov/pubmed/36316746
http://dx.doi.org/10.1186/s13098-022-00935-5

Ejemplares similares